These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 11873308

  • 1. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF.
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [Abstract] [Full Text] [Related]

  • 2. Molecular carcinogenesis of endometrial cancer.
    Liu FS.
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
    [Abstract] [Full Text] [Related]

  • 3. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF, Kurman RJ.
    Verh Dtsch Ges Pathol; 1997 Mar; 81():228-32. PubMed ID: 9474874
    [Abstract] [Full Text] [Related]

  • 4. [Endometrial carcinoma and precursor lesions].
    Djordjević B, Stanojević Z.
    Srp Arh Celok Lek; 2007 Mar; 135(3-4):230-4. PubMed ID: 17642468
    [Abstract] [Full Text] [Related]

  • 5. Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium.
    Lax SF.
    Pathology; 2007 Feb; 39(1):46-54. PubMed ID: 17365822
    [Abstract] [Full Text] [Related]

  • 6. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
    Lax SF.
    Virchows Arch; 2004 Mar; 444(3):213-23. PubMed ID: 14747944
    [Abstract] [Full Text] [Related]

  • 7. Theories of endometrial carcinogenesis: a multidisciplinary approach.
    Sherman ME.
    Mod Pathol; 2000 Mar; 13(3):295-308. PubMed ID: 10757340
    [Abstract] [Full Text] [Related]

  • 8. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF, Pizer ES, Ronnett BM, Kurman RJ.
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [Abstract] [Full Text] [Related]

  • 9. Histopathology of functional and neoplastic changes in cervix and endometrium.
    Dallenbach-Hellweg G.
    Verh Dtsch Ges Pathol; 1997 Jun; 81():240-4. PubMed ID: 9474876
    [Abstract] [Full Text] [Related]

  • 10. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T, Miller E, Duska L, Oliva E.
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [Abstract] [Full Text] [Related]

  • 11. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C, Dallenbach-Hellweg G, Schmidt D, Baehring J, Bielau S, von Knebel Doeberitz M, Gebert J.
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [Abstract] [Full Text] [Related]

  • 12. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
    Schmidt D, Horn LC.
    Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
    [Abstract] [Full Text] [Related]

  • 13. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
    Inoue M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
    [Abstract] [Full Text] [Related]

  • 14. Molecular and pathologic aspects of endometrial carcinogenesis.
    Hecht JL, Mutter GL.
    J Clin Oncol; 2006 Oct 10; 24(29):4783-91. PubMed ID: 17028294
    [Abstract] [Full Text] [Related]

  • 15. Pathology of Endometrial Carcinoma.
    Lax SF.
    Adv Exp Med Biol; 2017 Oct 10; 943():75-96. PubMed ID: 27910065
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA, Wethington SL, Cesari M, Chiappetta D, Olvera N, Shia J, Levine DA.
    Am J Surg Pathol; 2012 Dec 10; 36(12):1771-81. PubMed ID: 23154767
    [Abstract] [Full Text] [Related]

  • 17. Molecular analysis in endometrial cancer.
    Caduff RF, Svoboda-Neumann SM, Johnston CM, Bartos RE, Frank TS.
    Verh Dtsch Ges Pathol; 1997 Dec 10; 81():219-27. PubMed ID: 9474873
    [Abstract] [Full Text] [Related]

  • 18. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways.
    Lax SF, Kendall B, Tashiro H, Slebos RJ, Hedrick L.
    Cancer; 2000 Feb 15; 88(4):814-24. PubMed ID: 10679651
    [Abstract] [Full Text] [Related]

  • 19. K-ras mutation in tamoxifen-related endometrial polyps.
    Hachisuga T, Miyakawa T, Tsujioka H, Horiuchi S, Emoto M, Kawarabayashi T.
    Cancer; 2003 Nov 01; 98(9):1890-7. PubMed ID: 14584071
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP, van der Putten LJ, van Tilborg AA, Lurkin I, Zwarthoff EC, Pijnenborg JM, van den Berg-van Erp SH, Snijders MP, Bulten J, Visscher DW, Dowdy SC, Massuger LF.
    Gynecol Oncol; 2015 May 01; 137(2):245-51. PubMed ID: 25773202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.